Fertility preservation in the management of germ cell ovarian cancer

CME Journal of Gynecologic Oncology

Volumn 8, Issue 2, 2003, Pages 117-120

  Tangir, Jacob ^a   Schwartz, Peter E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dysgerminoma; Fertility preservation; Germ cell ovarian cancer; Immature teratoma; Yolk sac tumor

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; PLATINUM DERIVATIVE; VINCRISTINE;

ADOLESCENT DISEASE; ADVANCED CANCER; AGE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CONSERVATIVE TREATMENT; DYSGERMINOMA; EMBRYONAL CARCINOMA; FEMALE; FEMALE FERTILITY; FERTILITY; GERM CELL TUMOR; HUMAN; OVARY CANCER; REVIEW; SYMPTOMATOLOGY; TERATOMA; YOLK SAC TUMOR;

EID: 0142166748     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10 year review. Obstet Gynecol 1989;74:921-976.
2. Schwartz PE. Surgery of germ cell tumours of the ovary. Forum Trends Exper Clin Med 2000;10:355-367.
3. Kurman RJ, Norris HJ. Malignant germ cell tumors of the ovary. Human Pathol 1977;8:551-564.
4. Berek JS, Hacker NF. Nonepithelial ovarian and fallopian tube cancer. In: Practical Gynecologic Oncology. Berek JS, Hacker NF, eds. Lippincott Williams & Wilkins, Philadelphia, 2000:523-551.
5. Williams SD, et al. Ovarian germ-cell tumors. In: Principles and Practices of Gynecologic Oncology. Hoskins WJ, Perez CA, Young CY, eds. Lippincott Williams & Wilkins, Philadelphia, 2000:1060-1073.
6. Cannistra SA. Cancer of the ovary. N Engl J Med 1993;329:1550-1559.
7. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
8. Schwartz PE, Vidone R. Pregnancy following combination chemotherapy for a mixed germ cell tumor. Gynecol Oncol 1981;12:373-378.
9. Schwartz PE. Combination chemotherapy in the management of ovarian germ cell malignancies. Obstet Gynecol 1984;64:564-572.
10. Schwartz PE, Chambers S, Chambers J, Kohorn E, McIntosh S. Ovarian germ cell malignancies: The Yale University experience. Gynecol Oncol 1992;45:26-31.
11. Fishman DA, Schwartz PE. Current approaches to diagnosis and treatment of ovarian germ cell malignancies. Curr Opin Obstet Gynecol 1994;6:98-104.
12. Edraki B, Schwartz PE. Fertility and reproductive potential of patients with endodermal sinus tumors of the ovary treated conservatively. CME J Gynecol Oncol 1997;2:144-147.
13. Edraki B, Schwartz PE. Fertility after conservative treatment of ovarian immature teratoma. Int J Gynecol Cancer 1997;7:227-232.
14. Tangir J, Zelterman D, Ma W, Schwartz PE. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 2003;101:251-257.
15. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 1987;316:1435-1440.
16. Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Cisplatin, vinblastine and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 1089;111:22-27.
17. Williams SD, Blessing JA, Hatch KD, Homesley HD. Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 1991;9:1950-1955.
18. Gordon A, Lipton D, Woodruff JD. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol 1981;58:497-504.
19. Fujita M, Inque M, Tanizawa O, Minagawa J, Tamada T, Tani T. Retrospective review of 41 patients with endodermal sinus tumor of the ovary. Int J Gynecol Cancer 1993;3:329-335.
20. Gershenson D. Management of early ovarian cancer: Germ cell and sec cord-stromal tumors. Gynecol Oncol 1994;55:S62-S72.
21. Low JJH, Lewis CP, Crandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 2000;89:391-398.
22. Zanetta G, Bonazzi C, Cantu MG, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 2001;19:1015-1020.
23. Gershenson D. Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988;6:270-275.
24. Brewer M, Gershenson D, Herzog C, Mitchell M, Silva E, Wharton J. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma [comment]. J Clin Oncol 1999;17:2670-2675.
25. Meistrich M, Vassilopoulou-Sellin R, Lipshultz L. Gonadal dysfunction. In: Cancer, Principles and Practice of Oncology. Rosenberg S, ed. Lippincott-Raven, Philadelphia, 1997:2758-2773.
26. Chiarelli A, Marrett L, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 1999;150:245-254.
27. Chapman R, Sutcliffe S, Malpas J. Cytotoxic-induced ovarian failure in women with Hodgkin's Disease, I, Hormone function. JAMA 1979;242:1877-1881.
28. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 1992;166:788-793.
29. Green D, Zevon M, Lowrie G, Siegelstein N, Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med 1991;325:141-146.
30. Ezzat A, Raja M, Bakri Y, Subhi J, Memon M, Schwartz P, Stuart R. Malignant ovarian germ cell tumours - a survival and prognostic analysis. Acta Oncol 1999;38:455-460.